Mississippi, FDA urge people to stop ingesting livestock deworming medicine to fight COVID-19

Treating cows for disease in Uruguay
(Image credit: Pablo Porciuncula/AFP/Getty Images)

Researchers are studying what effects, if any, human versions of the lice and topical skin medicine ivermectin has against COVID-19, but health officials are warning people to stop buying and ingesting versions of the drug meant to deworm cows and horses. Mississippi's Department of Health said last Friday that 70 percent of recent calls to the state poison control center were related to people who ingested livestock ivermectin, which can cause a rash, vomiting, abdominal pain, neurological disorders, severe hepatitis, coma, or even death.

Most of the Mississippi ivermectin calls involved people with mild symptoms, but at least one person has reportedly been hospitalized for ivermectin toxicity. "You wouldn't get your chemotherapy at a feed store," Mississippi State Health Officer Dr. Thomas Dobbs said in a Zoom call last week. "I mean, you wouldn't want to treat your pneumonia with your animal's medication. It can be dangerous to get the wrong doses of medication, especially for something that's meant for a horse or a cow."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Peter Weber, The Week US

Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.